Metraipolis › archive › dc_01cc0fd8ebc4
Dynamic changes of serum α-fetoprotein predict the prognosis of bevacizumab plus immunotherapy in hepatocellular carcinoma — Europe PMC PMID:38905506
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/38905506
- DOI
- 10.1097/js9.0000000000001860
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T08:49:08.494Z
- SHA-256 of the archived text
39893733a09c830b772941cdc1d42087c250844ef2055604834dd483b15c4489- Stable URL of this page
https://metraipolis.com/documento/dc_01cc0fd8ebc4
How to cite
Dynamic changes of serum α-fetoprotein predict the prognosis of bevacizumab plus immunotherapy in hepatocellular carcinoma — Europe PMC PMID:38905506 — Europe PMC (en), https://europepmc.org/article/MED/38905506 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_01cc0fd8ebc4 (Metraipolis archive dc_01cc0fd8ebc4, sha256 39893733a09c830b772941cdc1d42087c250844ef2055604834dd483b15c4489)
BibTeX
@misc{dc01cc0fd8ebc4,
title = {Dynamic changes of serum α-fetoprotein predict the prognosis of bevacizumab plus immunotherapy in hepatocellular carcinoma — Europe PMC PMID:38905506},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/38905506},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_01cc0fd8ebc4; sha256 39893733a09c830b772941cdc1d42087c250844ef2055604834dd483b15c4489},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38905506. Agents can read the archived copy with the MCP tool read_document.